Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

 32.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 48.10
  • 52 Week Low: 29.75
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 392,173
  • Market Cap: 118.38m

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -80.5% -39.5%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 3.8 3.0
Pr/Book 2.0  
Latest F'cast
Revenue 13.2% 28.4%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CREO Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.01 (18.62) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-20 9.43 (23.46) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-22 27.20 (30.90) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-23 30.80 (24.50) (7.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CREO Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 39.56 (15.63) (3.75)p n/a n/a n/a n/a 0.0%
31-Dec-25 53.57 (4.33) (0.83)p n/a n/a n/a n/a 0.0%
31-Dec-26 70.00 4.00 1.42p 23.1 n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Latest CREO Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CREO Market Data

Currency UK Pounds
Share Price 32.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 48.10
52 Week Low 29.75
Volume 392,173
Shares Issued 361.48m
Market Cap 118.38m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
61.36% below the market average61.36% below the market average61.36% below the market average61.36% below the market average61.36% below the market average
18.92% below the sector average18.92% below the sector average18.92% below the sector average18.92% below the sector average18.92% below the sector average
Income Not Available
Growth
19.55% above the market average19.55% above the market average19.55% above the market average19.55% above the market average19.55% above the market average
39.39% above the sector average39.39% above the sector average39.39% above the sector average39.39% above the sector average39.39% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 15-Jul-2024

Time Volume / Share Price
16:23 8,783 @ 32.55p
15:04 30 @ 32.96p
14:09 47 @ 32.55p
13:12 10,000 @ 32.55p
12:43 4,000 @ 32.55p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page